Details
Stereochemistry | MIXED |
Molecular Formula | C23H31NO2.ClH |
Molecular Weight | 389.959 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=UXBPQRGCVJOTNT-UHFFFAOYSA-N
InChI=1S/C23H31NO2.ClH/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21;/h7-16,18,22H,6,17H2,1-5H3;1H
Methadyl Acetate is a narcotic analgesic with a long onset and duration of action. Methadyl Acetate is primarily a mu-type opioid receptor agonist and the drug decreases a patient's opioid use by preventing opioid withdrawal. Levacetylmethadol, the enantiomer of Methadyl Acetate, was approved in 1993 by the U.S. Food and Drug Administration for use in the treatment of opioid dependence. In 2001, levacetylmethadol was removed from the U.S. market due to reports of life-threatening ventricular rhythm disorders.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3ZD9WAO92T
Created by
admin on Sat Dec 16 05:33:42 GMT 2023 , Edited by admin on Sat Dec 16 05:33:42 GMT 2023
|
PRIMARY | |||
|
DBSALT002241
Created by
admin on Sat Dec 16 05:33:42 GMT 2023 , Edited by admin on Sat Dec 16 05:33:42 GMT 2023
|
PRIMARY | |||
|
38100
Created by
admin on Sat Dec 16 05:33:42 GMT 2023 , Edited by admin on Sat Dec 16 05:33:42 GMT 2023
|
PRIMARY | |||
|
DTXSID50959615
Created by
admin on Sat Dec 16 05:33:42 GMT 2023 , Edited by admin on Sat Dec 16 05:33:42 GMT 2023
|
PRIMARY | |||
|
38821-43-1
Created by
admin on Sat Dec 16 05:33:42 GMT 2023 , Edited by admin on Sat Dec 16 05:33:42 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD